Go Pro

DENTSPLY SIRONA (XRAY) Stock Price, News & Analysis

DENTSPLY SIRONA logo
$11.66 -0.46 (-3.80%)
As of 08/10/2026 04:00 PM Eastern

About DENTSPLY SIRONA Stock (NASDAQ:XRAY)

Advanced

Key Stats

Today's Range
$11.63
$12.12
50-Day Range
$9.64
$14.27
52-Week Range
$9.40
$14.86
Volume
5.74 million shs
Average Volume
5.34 million shs
Market Capitalization
$2.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.38
Consensus Rating
Hold

Company Overview

Dentsply Sirona Inc. (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care. Its consumables include dental implants, prosthetics and impression materials, while its equipment offerings cover digital imaging systems, treatment centers, and 3D printers designed for dental and orthodontic applications. Dentsply Sirona also provides software solutions that integrate treatment planning, data management and patient communication, helping clinicians streamline workflow and enhance patient outcomes.

Serving dental professionals in more than 120 countries, Dentsply Sirona maintains a global manufacturing footprint with facilities across North America, Europe, Latin America and Asia Pacific. The company supports its end markets through a combination of direct sales teams, distribution partners and digital channels. Its products are utilized by general practitioners, dental specialists and laboratories, reflecting a broad customer base in both developed and emerging markets.

Under the leadership of Chief Executive Officer Simon Campion, Dentsply Sirona emphasizes research and development to drive long-term growth. The company continues to invest in digital dentistry and minimally invasive clinical techniques, aiming to deliver innovative solutions that meet evolving patient needs. Dentsply Sirona’s focus on product quality, clinical education and customer support positions it as a key player in the global dental industry.

AI Generated. May Contain Errors.

DENTSPLY SIRONA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

XRAY MarketRank™: 

DENTSPLY SIRONA scored higher than 72% of companies evaluated by MarketBeat, and ranked 183rd out of 902 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DENTSPLY SIRONA has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 3 buy ratings, 9 hold ratings, and 3 sell ratings.

  • Upside Potential

    DENTSPLY SIRONA has a consensus price target of $13.38, representing about 14.8% upside from its current price of $11.66.

  • Amount of Analyst Coverage

    DENTSPLY SIRONA has only been the subject of 4 research reports in the past 90 days.

  • Read more about DENTSPLY SIRONA's stock forecast and price target.
  • Earnings Growth

    Earnings for DENTSPLY SIRONA are expected to grow by 4.83% in the coming year, from $1.45 to $1.52 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DENTSPLY SIRONA is -4.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DENTSPLY SIRONA is -4.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    DENTSPLY SIRONA has a PEG Ratio of 1.41. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    DENTSPLY SIRONA has a P/B Ratio of 1.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    15.01% of the float of DENTSPLY SIRONA has been sold short.
  • Short Interest Ratio / Days to Cover

    DENTSPLY SIRONA has a short interest ratio ("days to cover") of 5.95.
  • Change versus previous month

    Short interest in DENTSPLY SIRONA has recently increased by 2.46%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    DENTSPLY SIRONA does not currently pay a dividend.

  • Dividend Growth

    DENTSPLY SIRONA has been increasing its dividend for 13 years.

  • Dividend Sustainability

    Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 42.11% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.

  • News Sentiment

    DENTSPLY SIRONA has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 22 news articles for DENTSPLY SIRONA this week, compared to 6 articles on an average week.
  • Search Interest

    14 people have searched for XRAY on MarketBeat in the last 30 days. This is an increase of 75% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added DENTSPLY SIRONA to their MarketBeat watchlist in the last 30 days.
  • Cluster Insider Buying

    3 insiders have purchased shares of DENTSPLY SIRONA in the last three months. Multiple insiders buying is a strong bullish signal.

  • Net Insider Buying

    Over the last three months, insiders have purchased a net $351,179.00 in company stock, which represents 0.0151% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, DENTSPLY SIRONA insiders have bought more of their company's stock than they have sold. Specifically, they have bought $351,179.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    0.46% of the stock of DENTSPLY SIRONA is held by insiders.

  • Percentage Held by Institutions

    95.70% of the stock of DENTSPLY SIRONA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DENTSPLY SIRONA's insider trading history.
Receive XRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XRAY Stock News Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
Evercore ISI Keeps Their Hold Rating on DENTSPLY SIRONA (XRAY)
See More Headlines

XRAY Stock Analysis - Frequently Asked Questions

DENTSPLY SIRONA's stock was trading at $11.43 at the start of the year. Since then, XRAY stock has increased by 2.0% and is now trading at $11.66.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) released its quarterly earnings results on Thursday, August, 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.17. The company's revenue for the quarter was down 4.1% on a year-over-year basis.
Read the conference call transcript
.

DENTSPLY SIRONA subsidiaries include these companies: Propel Orthodontics LLC, Datum Dental Ltd., Straight Smile LLC, OraMetrix Inc, Recherche Techniques Dentaires, MIS Implants Technologies Ltd, Sirona Dental System, and more.

DENTSPLY SIRONA's top institutional shareholders include BlackRock Inc. (13.33%), Bank of New York Mellon Corp (0.77%), Deutsche Bank AG (0.13%) and GSA Capital Partners LLP (0.02%). Insiders that own company stock include Glenn Coleman, Gregory T Lucier, Brian T Gladden, Michael J Barber, James D Forbes and Brian P Mckeon.
View institutional ownership trends
.

Shares of XRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DENTSPLY SIRONA investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and ExxonMobil (XOM).

Company Calendar

Last Earnings
8/06/2026
Today
8/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:XRAY
CIK
818479
Employees
14,000
Year Founded
1899

Price Target and Rating

High Price Target
$17.00
Low Price Target
$9.00
Potential Upside/Downside
+14.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.75)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.04
P/E Growth
1.41
Net Income
-$598 million
Net Margins
-14.99%
Pretax Margin
-9.53%
Return on Equity
20.84%
Return on Assets
5.32%

Debt

Debt-to-Equity Ratio
1.48
Current Ratio
1.63
Quick Ratio
1.07

Sales & Book Value

Annual Sales
$3.68 billion
Price / Sales
0.63
Cash Flow
$5.77 per share
Price / Cash Flow
2.02
Book Value
$6.72 per share
Price / Book
1.74

Miscellaneous

Outstanding Shares
199,350,000
Free Float
198,437,000
Market Cap
$2.32 billion
Optionable
Optionable
Beta
0.85

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:XRAY) was last updated on 8/11/2026 by MarketBeat.com Staff.
From Our Partners